University of Southampton awarded ‘Centre of Excellence in Cyber Security Research and Education’
The University of Southampton has become one of the first organisations in the country to be awarded a unique ‘double’ as Centre of Excellence for Cyber Security Research and Education.
The university received a Gold Award for Education, which has been given by the National Cyber Security Centre (part of GCHQ). The given position belongs to a general UK government strategy determined to protect and promote the UK in a digital world. Through the command of Professor Vladimiro Sassone, the university has increased its expertise by launching a Cyber Security Academy, and a dedicated Research Group as a centre for world-leading education and research.
| UPDATED: 23:20, Mon, Jan 11, 2021
Link copied Sign up for FREE for the biggest new releases, reviews and tech hacks
SUBSCRIBE Invalid email
When you subscribe we will use the information you provide to send you these newsletters.
Sometimes they ll include recommendations for other related newsletters or services we offer.
Our Privacy Notice explains more about how we use your data, and your rights.
You can unsubscribe at any time.
Inside the Natural History Museum, a stunning 25 metre-long female blue whale skeleton suspends from the ceiling. Named ‘Hope’ by the museum as a symbol of humanity s power to shape a sustainable future, the remains have taken centre stage for the last three years. But cutting-edge science is now helping to unravel the history of Hope, giving an astonishing insight into the final years of the four-and-a-half-tonne creature.
11 Jan 2021 Share:
While ACE2 proteins are known to be the vehicle used by COVID-19 to enter the nose and lungs, the previously worrying increase in ACE2 found to occur as a result of interferon treatment has been shown to include only a new, short version of the protein that cannot bind the SARS-CoV-2 virus. This both bodes well for interferon treatments and might even provide some protection against the virus.
A shadow over the promising inhaled interferon beta COVID-19 therapy has been cleared with the discovery that although it appears to increase levels of ACE2 protein - coronavirus key entry point into nose and lung cells - it predominantly increases levels of a short version of that protein, which the virus cannot bind to.
A shadow over the promising inhaled interferon beta COVID-19 therapy has been cleared with the discovery that although it appears to increase levels of ACE2 protein - coronavirus key entry point into nose and lung cells - it predominantly increases levels of a short version of that protein, which the virus cannot bind to.
<div class="at-above-post addthis tool" data-url="https://www.metro.us/covid-19-patients-still-have/"></div>(Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Half a year later, COVID-19 patients still have symptoms Most patients hospitalized with COVID-19 have at least one symptom six months after […]<! AddThis Advanced Settings above via filter on get the excerpt ><! AddThis Advanced Settings below via filter on get the excerpt ><! AddThis Advanced Settings generic via filter on get the excerpt ><! AddThis Share Buttons above via filter on get the excerpt ><! AddThis Share Buttons below via filter on get the excerpt ><div class="at-below-post addthis tool" data-url="https://www.metro.us/covid-19-patients-still-have/"></div><